Summary: Depression and addiction are two of the most common co-occurring conditions in behavioral health, and the relationship between them is bidirectional. Depression drives substance use as self-medication: a person in emotional pain reaches for alcohol, opioids, benzodiazepines, or other substances to temporarily numb the hopelessness, fatigue, and emptiness that depression produces. Substance use then worsens the depression through neurochemical disruption, life consequences (job loss, relationship damage, financial problems), and the shame and guilt that addiction generates. This cycle, in which each condition fuels the other, is why treating depression without addressing the substance use (or vice versa) fails. The National Institute on Drug Abuse confirms that approximately half of individuals with a substance use disorder also have a co-occurring mental health condition, with depression being among the most common. Crosspointe Recovery in the Sherman Oaks area of Los Angeles treats addiction and depression simultaneously through an integrated dual diagnosis model using CBT, DBT, trauma-informed care, medication-assisted treatment, and individual and group therapy. Full continuum of care from medically supervised detox through residential rehab, PHP, IOP, and evening IOP. Co-ed, pet-friendly, phone-friendly. Most PPO, POS, and Open Access insurance accepted. Call 24/7 at (888) 615-7589.
Nobody plans to become addicted. Most people who develop a substance use disorder alongside depression did not set out to abuse drugs or alcohol. They were in pain. The depression made everything heavy. Getting out of bed felt impossible. Going to work felt impossible. Maintaining relationships felt impossible. And at some point, they discovered that a drink, a pill, or a line made the weight lift temporarily. The substance did what nothing else could: it provided relief.
The problem is that the relief is temporary, and the price is steep.
How Depression Drives Substance Use
Depression is not sadness. It is a clinical condition characterized by persistent changes in mood, energy, motivation, concentration, sleep, appetite, and the ability to experience pleasure. The National Institute of Mental Health reports that an estimated 21 million adults in the United States experience at least one major depressive episode each year.
When depression is untreated or inadequately treated, the emotional pain it produces is relentless. Alcohol provides temporary emotional numbing. Opioids produce a sense of warmth and comfort that depression strips away. Stimulants like cocaine and methamphetamine temporarily restore the energy and motivation that depression has taken. Benzodiazepines quiet the anxiety and restlessness that often accompanies depression.
In each case, the substance temporarily replaces what the depression has taken: pleasure, comfort, energy, calm. The brain learns the association: pain followed by substance followed by relief. This is the foundation of addiction, a hijacked reward pathway that drives compulsive behavior regardless of consequences.
How Substance Use Worsens Depression
The cruel irony of self-medicating depression with substances is that every substance that provides temporary relief makes the underlying depression worse over time.
Alcohol is a central nervous system depressant. While it may produce temporary euphoria or emotional numbing, chronic alcohol use disrupts serotonin and dopamine production, deepens depressive episodes, impairs sleep quality (even when it seems to help you fall asleep), and produces a rebound depressive effect as the alcohol wears off. The depression that follows a night of drinking is often worse than the depression that preceded it.
Opioids create physical dependence rapidly. As tolerance develops, the same dose produces less relief, driving dose escalation. Withdrawal between doses produces anxiety, irritability, and depression that is often more severe than the baseline depression. Chronic opioid use also suppresses the brain’s natural endorphin system, meaning that without opioids, the person has even less capacity for experiencing pleasure or comfort than they did before they started using.
Stimulants provide temporary bursts of energy and euphoria but are followed by crashes that produce profound depressive episodes. Chronic stimulant use (particularly methamphetamine and cocaine) causes lasting changes to dopamine systems that can produce anhedonia (inability to feel pleasure) for months after cessation.
Benzodiazepines provide rapid anxiety relief but produce dependence quickly. Withdrawal from benzodiazepines can produce severe depression, and chronic use has been associated with cognitive impairment and emotional blunting that compounds depressive symptoms.
Why Sequential Treatment Fails
The traditional approach to treating addiction and depression separately (treat the addiction first, then address the depression) fails for a straightforward reason: if the depression that drove the substance use is not treated, the emotional pain remains after detox and rehab. The patient leaves treatment physically sober but psychologically no different. The cravings return because the underlying condition is still generating the distress that substances temporarily relieved.
The National Institute on Drug Abuse states explicitly that integrated treatment, addressing both the substance use disorder and the co-occurring mental health condition simultaneously by the same clinical team, produces significantly better outcomes than treating either condition alone.
How Crosspointe Recovery Treats Addiction and Depression Together
Crosspointe Recovery’s dual diagnosis program treats addiction and depression within a single clinical framework from day one. This means the same clinical team addresses both conditions in every session, every treatment plan update, and every medication decision.
During detox, Dr. Javaherian, Crosspointe Recovery’s board-certified psychiatrist, evaluates each patient for co-occurring depression. This is critical because depressive symptoms often intensify during withdrawal, and distinguishing between substance-induced depression (which may resolve as detox progresses) and independent major depression (which requires ongoing treatment) requires clinical expertise and observation over time.
During residential treatment, CBT addresses the thought patterns that sustain both depression and substance use. DBT builds emotional regulation and distress tolerance skills that replace substance use as the primary coping mechanism. Trauma-informed care addresses the traumatic experiences that often underlie both conditions. Group therapy reduces the isolation that worsens both depression and addiction. Individual therapy provides space for deeper work on personal history, relational patterns, and the specific interplay between each patient’s depression and substance use.
Medication management is coordinated as an integrated protocol. Antidepressant medication (SSRIs, SNRIs) is prescribed in the context of the patient’s substance use history. MAT for addiction is prescribed in the context of the patient’s psychiatric status. All medications are managed by the same team so that pharmacological treatment for both conditions works together rather than at cross-purposes.
Through the full continuum, from detox through residential, PHP, IOP, and evening IOP, dual diagnosis treatment continues with the same clinical team. Depression does not resolve in 30 days. Addiction recovery does not end at discharge. The ongoing clinical relationship ensures that both conditions are monitored and treated through every phase of recovery.
Contact Crosspointe Recovery 24/7 at (888) 615-7589. If you need free help, contact the SAMHSA National Helpline.
Frequently Asked Questions About Addiction and Depression
Can depression cause addiction?
Depression does not directly “cause” addiction, but it significantly increases the risk. Untreated depression produces emotional pain that drives individuals to seek relief through substances (alcohol, opioids, benzodiazepines, stimulants). Over time, this self-medication pattern develops into physical and psychological dependence. The National Institute on Drug Abuse reports that approximately half of individuals with a substance use disorder also have a co-occurring mental health condition.
Does drinking make depression worse?
Yes. While alcohol may temporarily numb emotional pain, chronic alcohol use disrupts serotonin and dopamine production, impairs sleep quality, produces rebound depressive effects, and creates life consequences (job loss, relationship damage, financial problems) that deepen depression. The depression that follows drinking is often more severe than the depression that preceded it.
Can you treat addiction without treating depression?
You can, but the results are typically poor. If the depression that drove the substance use is not addressed, the emotional pain remains after detox and rehab, and the risk of relapse is significantly higher. Integrated dual diagnosis treatment that addresses both conditions simultaneously produces the strongest outcomes.
What is dual diagnosis treatment for addiction and depression?
Dual diagnosis treatment addresses both a substance use disorder and a co-occurring mental health condition (such as depression) simultaneously within a single clinical framework. At Crosspointe Recovery, this means the same clinical team treats both conditions in every session, coordinates medication for both conditions, and develops an integrated treatment plan. This approach is endorsed by the National Institute on Drug Abuse as producing significantly better outcomes than sequential or parallel treatment.
Does Crosspointe Recovery have a psychiatrist who treats both addiction and depression?
Yes. Dr. Javaherian, Crosspointe Recovery’s board-certified psychiatrist, specializes in the treatment of depression, anxiety, and addiction. Psychiatric evaluation begins during the detox phase, and medication management for both conditions is coordinated throughout treatment.
Can I bring my pet to treatment for addiction and depression at Crosspointe Recovery?
Yes. Crosspointe Recovery is pet-friendly. For individuals with depression, the companionship and routine that a pet provides can be therapeutically significant during treatment. Patients in residential programs can bring dogs and other pets to the Sherman Oaks facility.
Does insurance cover dual diagnosis treatment for addiction and depression?
Most major PPO, POS, and Open Access insurance plans cover dual diagnosis treatment, including medically supervised detox, residential rehabilitation, therapy, and psychiatric medication management. Federal and California mental health parity laws require insurers to cover mental health and substance use treatment at parity with medical benefits. Medicare and Medicaid are not accepted. Call (888) 615-7589 for free insurance verification.
